Breaking News Instant updates and real-time market news.

CYBR

CyberArk

$45.41

0.75 (1.68%)

07:41
02/15/18
02/15
07:41
02/15/18
07:41

CyberArk reports Q4 adjusted EPS 41c, consensus 36c

Reports Q4 revenue $80.4M, consensus $75.58M.

  • 15

    Feb

  • 26

    Feb

  • 14

    Mar

  • 29

    Mar

CYBR CyberArk
$45.41

0.75 (1.68%)

01/26/18
JMPS
01/26/18
NO CHANGE
JMPS
Fortinet, Proofpoint targets raised after positive checks at JMP Securities
JMP Securities analyst Erik Suppiger said his industry discussions lead him to believe the cyber-security spending environment has been relatively healthy and that security remains top of mind for enterprise buyers. Demand for internal security technologies that monitor and detect intrusions or technologies that add additional layers of security for specific assets is benefiting vendors such as CyberArk Software (CYBR), Proofpoint (PFPT), and Imperva (IMPV), Suppiger said. Given his positive channel checks and an appreciation in valuation multiples, Suppiger raised his price target on Proofpoint to $115 from $95 and on Fortinet (FTNT) to $54 from $41.
01/04/18
DBAB
01/04/18
NO CHANGE
Target $47
DBAB
Hold
Deutsche incrementally cautious on CyberArk after field discussions
Deutsche Bank analyst Gray Powell says he's incrementally cautious on CyberArk after speaking with a number of contacts in the privileged account management space. The analyst believes the bulk of the PAM market's growth going forward will be driven by mid-market companies that are more price sensitive than larger enterprises. Competition in this segment of the security software market is on the rise and CyberArk will increasingly compete against smaller vendors with cheaper solutions, Powell tells investors in a research note. He keeps a Hold rating on the shares with a $47 price target.
11/02/17
BOFA
11/02/17
UPGRADE
BOFA
Neutral
CyberArk upgraded to Neutral from Underperform at BofA/Merrill
09/21/17
JMPS
09/21/17
NO CHANGE
Target $53
JMPS
Outperform
CyberArk named a favorite pick after pullback at JMP Securities
JMP Securities analyst Erik Suppiger noted CyberArk shares have declined about 25% since it reported Q1 results in May after falling short of expectations in the past two quarters, though his recent checks give him confidence in demand and he thinks management has addressed some sales execution issues. Given the pullback and his positive channel checks, Suppiger sees the stock as a favorite name and reiterates his Outperform rating and $53 price target on CyberArk shares.

TODAY'S FREE FLY STORIES

ADTN

Adtran

$10.92

-0.05 (-0.46%)

11:51
12/18/18
12/18
11:51
12/18/18
11:51
Earnings
Adtran announces CAF II solutions to address rural U.S. areas without broadband »

Adtran announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:50
12/18/18
12/18
11:50
12/18/18
11:50
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

FB

Facebook

$143.24

2.93 (2.09%)

11:47
12/18/18
12/18
11:47
12/18/18
11:47
Hot Stocks
Facebook COO Sandberg says needs to step up efforts to curb misinformation »

Facebook COO Sheryl…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMT

American Tower

$162.39

1.47 (0.91%)

11:45
12/18/18
12/18
11:45
12/18/18
11:45
Conference/Events
American Tower management to meet with SunTrust »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

CPRX

Catalyst Pharmaceuticals

$2.43

0.085 (3.62%)

, ENDP

Endo

$9.45

(0.00%)

11:43
12/18/18
12/18
11:43
12/18/18
11:43
Hot Stocks
Catalyst Pharmaceuticals, Endo sign definitive agreement for vigabatrin tablets »

Catalyst Pharmaceuticals…

CPRX

Catalyst Pharmaceuticals

$2.43

0.085 (3.62%)

ENDP

Endo

$9.45

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$17.39

-0.26 (-1.47%)

11:40
12/18/18
12/18
11:40
12/18/18
11:40
Options
Put buyer in Teva Pharmaceuticals appears to adjust week-old position »

Put buyer in Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:40
12/18/18
12/18
11:40
12/18/18
11:40
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

AMTB

Mercantil Bank

$12.30

(0.00%)

11:39
12/18/18
12/18
11:39
12/18/18
11:39
Hot Stocks
Breaking Hot Stocks news story on Mercantil Bank »

Mercantil Bank Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

AXGN

AxoGen

$26.39

-1.14 (-4.14%)

11:38
12/18/18
12/18
11:38
12/18/18
11:38
Periodicals
AxoGen mentioned cautiously in a Seeking Alpha article 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMTB

Mercantil Bank

$12.30

(0.00%)

11:34
12/18/18
12/18
11:34
12/18/18
11:34
Hot Stocks
Breaking Hot Stocks news story on Mercantil Bank »

Mercantil Bank Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

MXIM

Maxim Integrated

$52.71

0.51 (0.98%)

, INTC

Intel

$48.02

0.93 (1.97%)

11:30
12/18/18
12/18
11:30
12/18/18
11:30
Recommendations
Maxim Integrated, Intel, Inphi, Cisco, Macom analyst commentary  »

Cisco acquisition of…

MXIM

Maxim Integrated

$52.71

0.51 (0.98%)

INTC

Intel

$48.02

0.93 (1.97%)

IPHI

Inphi

$33.50

0.96 (2.95%)

CSCO

Cisco

$44.04

-0.17 (-0.38%)

MTSI

Macom

$15.86

0.46 (2.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

  • 07

    Jan

  • 08

    Jan

  • 10

    Jan

  • 04

    Mar

CBIO

Catalyst Biosciences

$8.93

-0.33 (-3.56%)

11:25
12/18/18
12/18
11:25
12/18/18
11:25
Conference/Events
Catalyst Biosciences to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

WCG

WellCare

$231.35

-5.81 (-2.45%)

11:25
12/18/18
12/18
11:25
12/18/18
11:25
Conference/Events
WellCare management to meet with Wolfe Research »

Healthcare Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PM

Philip Morris

$78.59

-2.8 (-3.44%)

, BTI

British American Tobacco

$32.48

-0.25 (-0.76%)

11:23
12/18/18
12/18
11:23
12/18/18
11:23
On The Fly
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's top…

PM

Philip Morris

$78.59

-2.8 (-3.44%)

BTI

British American Tobacco

$32.48

-0.25 (-0.76%)

IMBBY

Imperial Brands

$0.00

(0.00%)

TSLA

Tesla

$346.73

-1.57 (-0.45%)

ORCL

Oracle

$45.66

-0.06 (-0.13%)

OSTK

Overstock.com

$13.06

-0.45 (-3.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jan

  • 16

    Jan

  • 17

    Jan

USO

United States Oil Fund

$10.10

-0.345 (-3.30%)

11:20
12/18/18
12/18
11:20
12/18/18
11:20
Options
New 52wk lows prompt bullish risk reversal in US Oil ETF »

New 52wk lows prompt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPS

Cooper-Standard

$64.54

1.26 (1.99%)

11:18
12/18/18
12/18
11:18
12/18/18
11:18
Hot Stocks
Cooper-Standard announces plans for new world headquarters »

Cooper Standard announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GT

Goodyear Tire

$20.87

0.31 (1.51%)

11:17
12/18/18
12/18
11:17
12/18/18
11:17
Hot Stocks
Goodyear Tire to expand capacity of Slovenian manufacturing facility »

Goodyear announced plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
12/18/18
12/18
11:17
12/18/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
12/18/18
12/18
11:16
12/18/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LILAK

Liberty Global LiLAC

$16.32

0.01 (0.06%)

11:13
12/18/18
12/18
11:13
12/18/18
11:13
Conference/Events
Liberty Global LiLAC management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

EWZ

MSCI Brazil Index

$37.67

0.3644 (0.98%)

11:10
12/18/18
12/18
11:10
12/18/18
11:10
Options
Four-way option spread in Brazil Fund as shares climb 1.1% »

Four-way option spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:10
12/18/18
12/18
11:10
12/18/18
11:10
General news
Treasury announced $70 B in shorter dated bill auctions for Thursday »

Treasury announced $70 B…

11:10
12/18/18
12/18
11:10
12/18/18
11:10
General news
Atlanta Fed's Q4 GDPNow estimate was trimmed to 2.9% »

Atlanta Fed's Q4…

RBS

RBS

$5.36

0.15 (2.88%)

11:09
12/18/18
12/18
11:09
12/18/18
11:09
Hot Stocks
RBS appoints Katie Murray as CFO »

RBS announces the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:08
12/18/18
12/18
11:08
12/18/18
11:08
General news
8-Week Bill Announcement Offering Amount data reported »

8-Week Bill Announcement…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.